Patients and parents’ organisations
Academic paediatric oncologists and haematologists and academic researchers
Representatives from biopharma companies
Regulatory networks (FDA, EMA, TGA, Health-Canada, PMDA) and health technology assessment authorities
ACCELERATE engages, where possible, in policy initiatives which apply to the field of childhood cancer policy. We make sure our voice is heard by prioritising for the following goals:
Accelerating science-driven development of pediatric oncology drugs based on mechanism-of-action rather than adult indication.
Facilitating international cooperation and collaboration among stakeholders.
Improving early-access to new anti-cancer drugs in development for children and adolescents.
Setting-up long-term follow-up of children and adolescents exposed to new drugs.